Pharma Intermediates Winners

Hunter, David
March 2003
Chemical Week;3/19/2003, Vol. 165 Issue 11, p7
Trade Publication
Comments on the speech of Andrew Liveris, business group president for perfomance chemicals of Dow Chemical, at Socma's Informex show on February 19, 2003, about pharmaceutical intermediates. Views on outsourcing; Theme of the speech; Maturation of the small-molecule segment.


Related Articles

  • EPCA 2006: Industry Faces 'Tectonic Shift.'. Young, Ian // Chemical Week;10/4/2006, Vol. 168 Issue 33, p13 

    The article reports on the growth of chemical companies with petrochemicals business according to Dow Chemical Co. CEO Andrew Liveris. Liveris predicted the emergence of companies that invest in petrochemicals. These include firms producing petrochemicals from oil and gas in the Mideast and...

  • business & finance news.  // Chemical Week;11/10/2004, Vol. 166 Issue 37, p9 

    Presents news briefs on the chemical industry as of November 10, 2004. Appointment of executive Andrew Liveris at Dow Chemical; Information on the amendment signed by FMC regarding its credit agreement.

  • Dow's CEO Discusses Strategy.  // Chemical Market Reporter;2/7/2005, Vol. 267 Issue 6, p22 

    The article presents an interview with Andrew Liveris, president and CEO of the Dow Chemical Co. He said that the company's 2005 capital expenditure budget is $1.5 billion, which is up from 2004, but still well below depreciation. Liveris said that the 2005 budget not only enables the company to...

  • Dow asks for help on natural gas. Crow, Patrick // Chemical Market Reporter;11/14/2005, Vol. 268 Issue 17, p8 

    Reports that Dow Chemical Co. president and CEO Andrew Liveris has testified on behalf of the company and the American Chemistry Council at a U.S. House Appropriations joint committee on the impact of high and volatile natural gas prices on the chemical industry. Concerns of Liveris over the...

  • Dow Names New 'Portfolio Team' and Business Leaders. Westervelt, Robert // Chemical Week;1/28/2004, Vol. 166 Issue 3, p40 

    Provides information on the portfolio team established by Dow Chemical. Appointment of Andrew Liveris as COO and president of the portfolio team; Members of the portfolio team; Duties and responsibilities of the team.

  • Dow's Liveris answers criticism with numbers. ESPOSITO, FRANK // Crain's Detroit Business;6/9/2014, Vol. 30 Issue 23, p0015 

    The article highlights the response of Dow Chemical Co. chief executive officer (CEO) Andrew Liveris to criticisms about the company's poor operational track record across multiple business segments. Topics discussed include the company's financial performance in the first quarter of 2014, its...

  • Dow posts gains, says lower oil prices won't hurt cost position.  // Chemical Week;10/20/2014, Vol. 176 Issue 26, p7 

    The article reports that chemical company Dow posted an increase for its 2014 third-quarter net income. Topics discussed include factors contributing to the increase of Dow Chemical's margins, increase of revenues, reported adjusted earnings and sales and chief executive officer (CEO) Andrew...

  • The human element. Ferguson, Adele // BRW;1/25/2007, Vol. 29 Issue 3, p80 

    The article focuses on the importance of human resource in turning Dow Chemical Co. into the world's biggest, most profitable and most respected chemical company. This transformation is the mission of Australian-born chairman and chief executive officer Andrew Liveris. Like any strategy, its...

  • news briefs.  // Chemical Week;1/7/2013, Vol. 175 Issue 1, p4 

    The article presents chemical industry news briefs as of January 7, 2013. Andrew Liveris, the chief executive officer of the chemical company Dow Chemical Co., will receive an award. Francis Malecha has been appointed as the president of the mineral company Compass Minerals. The petroleum...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics